New developments in the treat ment of patients with multiple myeloma .First analysis of HOVON‐65/GMMG‐HD4ran domized phase Ⅲ trial comparing bortezomib,adriamycin,dexamethasone(PAD)vs VADasinduction treat ment prior to high dose melphalan in patients with ......